Table 7

Drug sales (proportion of the cost per group) for dyspepsia, gastro-oesophageal reflux disease, and “gastritis” in Sweden in 1996; total cost US$170 million67

Percentage of cost
Antacids/alginates6
H2 receptor antagonists21
Proton pump inhibitors67
Prokinetics6